🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
120 Servings
Other Combinations Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Calcium
17.5 mg (1% DV)
0.1 mg (1% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 0.1mg
Protease
Serrapeptase

Other Ingredients

Hydroxypropyl Methylcellulose Water

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Kosher Gluten Free Dairy Free

Product Information

📋 Directions for Use

Recommended Dose: 1 capsule daily on an empty stomach, 1 hour before or 2 hours after a meal. More may be taken as needed. Consult a physician before use if you are pregnant or nursing, taking medications or have a medical condition.

⚠️ Warnings & Precautions

Do not use if safety seal is broken or missing.

Keep out of reach of children.

🧪 Formulation Notes

Serrapeptase Pro With serrapeptase, protease Thera-blend, calcium and magnesium.

Serrapeptase Pro is a potent blend of proteolytic enzymes that supports healthy cardiovascular, circulatory and immune function, as well as supporting the body's natural response to systemic stress. Serrapeptase is a versatile, clinically studied enzyme that decreases the body's recovery period after physical activity or exertion, helpful for those with active lifestyles.

High-Potency Serrapeptase Blend With potent proteolytic enzymes

Support for systemic stress For whole-body enzyme support

Vegan

Kosher

Contains no: casein, crustaceans, eggs, fish, gluten, milk, nuts, sesame, shellfish, soy, wheat; Artificial colors, fillers or flavors Non-GMO

Additional Information

Scan for Protocol

Product Details

UPC / SKU 6 70480 30067 1
DSLD Entry Date 2025-07-24
Product Type Other Combinations
Form Bar
DSLD ID 334833
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →